Recent Progress in Immunotherapy for RRMM: Updates from EHA 2023 Congress

Recent Progress in Immunotherapy for RRMM: Updates from EHA 2023 Congress

Bibliographic Details
Main Author:	María-Victoria Mateos
Format:	Article
Language:	English
Published:	THE HEALTHBOOK COMPANY LTD. 2023-06-01
Series:	healthbook TIMES. Oncology Hematology
Online Access:	https://doi.org/10.36000/hbT.OH.2023.16.111

Similar Items

EHA2021 Virtual Congress Abstract Book
Published: (2021-06-01)

Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies
by: Hermann Einsele, et al.
Published: (2020-08-01)

EHA Research Roadmap on Hemoglobinopathies and Thalassemia: An Update
by: Achille Iolascon, et al.
Published: (2019-06-01)

The EHA2021 Annual Congress Award Winners: Celebrating Excellence in Hematology
by: John Gribben, et al.
Published: (2021-06-01)

Bispecific T cell engagers targeting CD20/CD3 in B-cell lymphoma: latest updates from 2023 EHA annual meeting
by: Shenhe Jin, et al.
Published: (2023-12-01)

The EHA Research Roadmap: Anemias
by: Achille Iolascon, et al.
Published: (2021-07-01)

Flavor of Iron at EHA2023: Novel Regulatory Mechanisms and Therapeutic Options for the Correction of Anemia
by: Francesca Vinchi, et al.
Published: (2023-10-01)

S192: TALQUETAMAB (TAL) + DARATUMUMAB (DARA) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED TRIMM-2 RESULTS
by: Nizar J Bahlis, et al.
Published: (2023-08-01)

The EHA Research Roadmap: Malignant Lymphoid Diseases
by: Martin Dreyling, et al.
Published: (2022-06-01)

The EHA Research Roadmap: Infections in Hematology
by: Catherine Cordonnier, et al.
Published: (2021-12-01)

The EHA Research Roadmap: normal hematopoiesis
by: Jaffredo, T, et al.
Published: (2021)

The EHA Research Roadmap: Platelet Disorders
by: Carlo Balduini, et al.
Published: (2021-07-01)

The EHA Research Roadmap: Transfusion Medicine
by: Simon J. Stanworth, et al.
Published: (2022-02-01)

The EHA Research Roadmap: Normal Hematopoiesis
by: Thierry Jaffredo, et al.
Published: (2021-12-01)

Highlights in Multiple Myeloma Treatment from EHA2021
by: Carmen de Ramon Ortiz
Published: (2021-10-01)

The Renovated Face of EHA Classical Master Class: A Survey-based Evaluation on Behalf of the EHA Campus Working Group
by: Carmelo Gurnari, et al.
Published: (2022-10-01)

The EHA Research Roadmap: Malignant Myeloid Diseases
by: Hartmut Döhner, et al.
Published: (2021-09-01)

Correction Notice: The EHA Research Roadmap: Anemias
Published: (2021-10-01)

Telemedicine networks of EHAS Foundation in Latin America
by: Ignacio ePrieto-Egido, et al.
Published: (2014-10-01)

Fair Pricing of Innovative Medicines: An EHA Position Paper
by: Anton Hagenbeek, et al.
Published: (2020-10-01)

Electrical and Photodetector Characteristics of Schottky Structures Interlaid with P(EHA) and P(EHA-co-AA) Functional Polymers by the iCVD Method
by: Selçuk Demirezen, et al.
Published: (2023-11-01)

ESC Congress 2023
by: Charlotte Rowbottom
Published: (2023-09-01)

Update on the challenges and recent advances in cancer immunotherapy
by: Baronzio G, et al.
Published: (2013-06-01)

Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
by: Meletios A. Dimopoulos, et al.
Published: (2021-02-01)

Recent progress in allergen immunotherapy
by: Takumi Takizawa
Published: (2024-10-01)

The EHA Research Roadmap: Hematopoietic Stem Cell Gene Therapy
by: Luigi Naldini, et al.
Published: (2022-02-01)

CLL and Lymphoma Studies at EHA2021 and 16-ICML
by: Davide Rossi
Published: (2021-10-01)

The EHA Research Roadmap: Hematopoietic Stem Cells and Allotransplantation
by: Willem Fibbe, et al.
Published: (2022-05-01)

The EHA Research Roadmap: Blood Coagulation and Hemostatic Disorders
by: Sabine Eichinger, et al.
Published: (2021-10-01)

Access to Affordable Orphan Medicines in Europe: An EHA Position Paper
by: Giampaolo Merlini, et al.
Published: (2020-10-01)

Double Hit Lymphoma Diagnosis and Treatment in Europe—A Cross-Sectional Survey of Clinical Practice by the EHA Lymphoma Working Party (EHA LyG)
by: Igor Aurer, et al.
Published: (2020-12-01)

Cyclophosphamide addition to pomalidomide/dexamethasone is not necessarily associated with universal benefits in RRMM.
by: Hyunkyung Park, et al.
Published: (2022-01-01)

EHA Endorsement of the European Guidelines for Myelodysplastic Syndromes, MDS-RIGHT
by: Sabine Blum, et al.
Published: (2021-09-01)

The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies
by: Hermann Einsele, et al.
Published: (2021-10-01)

EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer
by: Anna Falanga, et al.
Published: (2022-08-01)

EHA Guidance Document The process of CAR-T cell therapy in Europe
Published: (2019-08-01)

Personalized Treatment for Hematologic Diseases in Europe: An EHA Position Paper
by: Ulrich Jäger, et al.
Published: (2020-10-01)

Study on fault diagnosis algorithms of EHA based on CNN-SVM
by: LI Xudong, et al.
Published: (2023-02-01)

Reporting From the First EHA Research Conference: Exciting Science With Panoramic Views
by: Melania Tesio
Published: (2023-01-01)

PB2703: ISA-KD IN NOT TRANSPLANT CANDIDATES RRMM. EXPERIENCE IN REAL LIFE.
by: Dunia De Miguel Llorente, et al.
Published: (2023-08-01)